Zanubrutinib Interactions
There are 524 drugs known to interact with zanubrutinib, along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 231 are major, 290 are moderate, and 3 are minor.
- View all 524 medications that may interact with zanubrutinib
- View zanubrutinib alcohol/food interactions (2)
- View zanubrutinib disease interactions (6)
Most frequently checked interactions
View interaction reports for zanubrutinib and the medicines listed below.
- Acidophilus (lactobacillus acidophilus)
- Advair HFA (fluticasone / salmeterol)
- Aimovig (erenumab)
- Allegra (fexofenadine)
- Aloxi (palonosetron)
- Alpha Lipoic Sustain (alpha-lipoic acid/biotin)
- Alvesco (ciclesonide)
- Ambien (zolpidem)
- Aspir 81 (aspirin)
- Centrum Silver (multivitamin with minerals)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- D3 (cholecalciferol)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Imodium (loperamide)
- Iron Sulfate (ferrous sulfate)
- Januvia (sitagliptin)
- Jardiance (empagliflozin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Nexium (esomeprazole)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Paxlovid (nirmatrelvir / ritonavir)
- Percocet (acetaminophen / oxycodone)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Zanubrutinib alcohol/food interactions
There are 2 alcohol/food interactions with zanubrutinib.
Zanubrutinib disease interactions
There are 6 disease interactions with zanubrutinib which include:
Report options
More about zanubrutinib
- zanubrutinib consumer information
- Compare alternatives
- Reviews (54)
- Side effects
- Dosage information
- During pregnancy
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Lenalidomide
Lenalidomide (Revlimid) is used to treat multiple myeloma, mantle cell lymphoma, follicular ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
